Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Leukemia, Myeloid, Acute 132Myelodysplastic Syndromes 57Leukemia 32Leukemia, Myelomonocytic, Chronic 23Recurrence 18Lymphoma, Large B-Cell, Diffuse 10Myeloproliferative Disorders 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasms 8Congenital Abnormalities 7Primary Myelofibrosis 6Melanoma 6Hodgkin Disease 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Blast Crisis 5Thrombocythemia, Essential 4Polycythemia Vera 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma 4Leukemia, Monocytic, Acute 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Neoplasm Metastasis 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Accelerated Phase 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2

Interventions

Cyclophosphamide 16Temozolomide 13Vincristine 10Irinotecan 8Melphalan 7Doxorubicin 7Topotecan 6Granulocyte Colony-Stimulating Factor 6Busulfan 6fludarabine 5cabozantinib 5Etoposide 5Drug Therapy 5liposomal doxorubicin 4Sirolimus 4Ifosfamide 4Filgrastim 4regorafenib 3pegfilgrastim 3irinotecan sucrosofate 3fludarabine phosphate 3Zoledronic Acid 3Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3Gemcitabine 3Cisplatin 3Bone Marrow Transplantation 3Albumin-Bound Paclitaxel 3pegylated granulocyte colony-stimulating factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Ewing × Decitabine × Clear all
NCT01241162 2017-05-09

Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma

University of Louisville

Phase 1 Completed
19 enrolled
CNSSarcoma

Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡